Ovum raises AUD 4M seed to scale its women's health AI

What's the deal? Australian health tech startup Ovum AIDealroom has a profile for this one. Try Dealroom → has raised AUD 4 million in seed funding to expand its AI-powered women's health platform and keep building what it calls the first longitudinal dataset designed specifically around women's health.

The round was led by Admiralty Capital GroupDealroom has a profile for this one. Try Dealroom →, with participation from AntlerDealroom has a profile for this one. Try Dealroom →, Giant LeapDealroom has a profile for this one. Try Dealroom → and Brisbane AngelsDealroom has a profile for this one. Try Dealroom →. LaunchVicDealroom has a profile for this one. Try Dealroom → also increased its investment through the Alice Anderson FundDealroom has a profile for this one. Try Dealroom →.

Founded in 2022 by Dr Ariella Heffernan-Marks, Ovum helps women track health patterns over time and advocate for themselves in clinical settings. Its users span ages 15 to 84 and more than 20 conditions, from ADHD and migraines to PCOS and menopause. The company says it has captured more than 60,000 health insights and facilitated over 113,000 AI health conversations to date.

Why it matters: The raise follows a AUD 1.7 million pre-seed round and has tripled the company's valuation. The presence of impact-focused backers like Giant Leap and government player LaunchVic alongside the lead points to an early-stage women's health bet that is part mission, part market opportunity — with investors treating the dataset itself, not just the app, as the asset worth funding.

Read more: SmartCompany